FTH Faeth Therapeutics, Inc. - Common Stock

NASDAQ · · View on SEC EDGAR ↗
$33.31
Price · Aug 19, 2026
Fundamentals as of Aug 4, 2026
52W Range
$13–$38
81% of range
Analyst Rating
BUY
14 analysts
Price Target
$54
+64% upside
P/E (TTM)
—
ROE
—
Net Profit Margin
—

FTH Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$33.31
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$13 – $38

FTH Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income —
EPS —
Free Cash Flow —
Margins —

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
FTH
Peer Median

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
FTH
Peer Median

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
FTH
Peer Median

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
FTH
Peer Median

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
FTH
Peer Median

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
FTH
Peer Median

FTH Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 14 analysts
  • Strong Buy 6 42.9%
  • Buy 7 50.0%
  • Hold 1 7.1%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

10 analysts · 2026-08-15
Median target $55.00 +65.1%
Mean target $54.50 +63.6%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
-3.7%
Period EPS Actual EPS Est Surprise
June 30, 2026 $-2.84 $-3.08 0.24%
March 31, 2026 $-28.79 $-0.63 -28.2%
Dec. 31, 2025 $-3.74 $-4.86 1.1%
Sept. 30, 2025 $-3.62 $-4.15 0.53%
June 30, 2025 $-3.91 $-5.66 1.7%
March 31, 2025 $-5.40 $-4.56 -0.84%
Dec. 31, 2024 $-6.20 $-5.59 -0.61%

Peer comparison (GICS sub-industry) Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
FTH — — — — — —
OLMA $2.03B -13.4 — — -39.4% —
DSGN $567M -7.7 — — -32.8% —
CADL $310M -7.8 — — -53.7% —
ANNX $750M -3.7 — — -100.7% —
AURA $347M -3.1 -29.7% -1601.4% -68.2% —
RIGL $784M 2.2 64.1% 124.7% 155.1% —
IMMX $277M -5.9 — — -59.8% —
ACHV — -4.0 — — — —

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Company insiders 3 insiders · 3 officers · 1 directors

Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Anand Kiran Parikh President and CEO July 21, 2026 A 817,699 1 0 $55,447
Brian C Stephenson Chief Financial Officer July 1, 2026 P 46,688 22 0 $1,133,316
Josiah Craver PAO July 21, 2026 A — 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 2 ETFs

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
IWC · iShares Trust 0.01% 3,192 SH Aug. 8, 2026 Daily
VXF · VANGUARD INDEX FUNDS 0.00% 10,115 SH Aug. 8, 2026 Daily